TerminatedPhase 1NCT02722512

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
Stewart Goldman, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Intervention
Heat Shock Protein Peptide Complex-96 (HSPPC-96)(biological)
Enrollment
10 enrolled
Eligibility
3-21 years · All sexes
Timeline
2016 – 2019

Study locations (1)

Collaborators

Northwestern University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02722512 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials